Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression. - Kushner MH; Ory V; Graham GT; Sharif GM; Kietzman WB; Thevissen S; Yuan M; Schmidt MO; Wellstein A; Riegel AT (EMBO reports, 2020)